Over-the-counter antibiotic dispensing by pharmacies: a standardised patient study in Udupi district, India.
India
antibiotic
global health
pharmacy
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
2019
2019
Historique:
received:
26
07
2019
revised:
28
09
2019
accepted:
05
10
2019
entrez:
5
12
2019
pubmed:
5
12
2019
medline:
5
12
2019
Statut:
epublish
Résumé
Antimicrobial resistance is a global health emergency, and one of the contributing factors is overuse and misuse of antibiotics. India is one of the world's largest consumers of antibiotics, and inappropriate use is potentially widespread. This study aimed to use standardised patients (SPs) to measure over-the-counter antibiotic dispensing in one region. Three adults from the local community in Udupi, India, were recruited and trained as SPs. Three conditions, in both adults and children, were considered: diarrhoea, upper respiratory tract infection and acute fever. Adult SPs were used as proxies for the paediatric cases. A total of 1522 SP interactions were successfully completed from 279 pharmacies. The proportion of SP interactions resulting in the provision of an antibiotic was 4.34% (95% CI 3.04% to 6.08%) for adult SPs and 2.89% (95% CI 1.8% to 4.4%) for child SPs. In the model, referral to another provider was associated with an OR 0.38 (95% CI 0.18 to 0.79), the number of questions asked was associated with an OR 1.54 (95% CI 1.30 to 1.84) and an SP-pharmacist interaction lasting longer than 3 min was associated with an OR 3.03 (95% CI 1.11 to 8.27) as compared with an interaction lasting less than 1 min. Over-the-counter antibiotic dispensing rate was low in Udupi district and substantially lower than previously published SP studies in other regions of India. Dispensing was lowest when pharmacies referred to a doctor, and higher when pharmacies asked more questions or spent more time with clients.
Sections du résumé
BACKGROUND
BACKGROUND
Antimicrobial resistance is a global health emergency, and one of the contributing factors is overuse and misuse of antibiotics. India is one of the world's largest consumers of antibiotics, and inappropriate use is potentially widespread. This study aimed to use standardised patients (SPs) to measure over-the-counter antibiotic dispensing in one region.
METHODS
METHODS
Three adults from the local community in Udupi, India, were recruited and trained as SPs. Three conditions, in both adults and children, were considered: diarrhoea, upper respiratory tract infection and acute fever. Adult SPs were used as proxies for the paediatric cases.
RESULTS
RESULTS
A total of 1522 SP interactions were successfully completed from 279 pharmacies. The proportion of SP interactions resulting in the provision of an antibiotic was 4.34% (95% CI 3.04% to 6.08%) for adult SPs and 2.89% (95% CI 1.8% to 4.4%) for child SPs. In the model, referral to another provider was associated with an OR 0.38 (95% CI 0.18 to 0.79), the number of questions asked was associated with an OR 1.54 (95% CI 1.30 to 1.84) and an SP-pharmacist interaction lasting longer than 3 min was associated with an OR 3.03 (95% CI 1.11 to 8.27) as compared with an interaction lasting less than 1 min.
CONCLUSION
CONCLUSIONS
Over-the-counter antibiotic dispensing rate was low in Udupi district and substantially lower than previously published SP studies in other regions of India. Dispensing was lowest when pharmacies referred to a doctor, and higher when pharmacies asked more questions or spent more time with clients.
Identifiants
pubmed: 31798998
doi: 10.1136/bmjgh-2019-001869
pii: bmjgh-2019-001869
pmc: PMC6861094
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e001869Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Clin Infect Dis. 2019 Aug 1;69(4):563-570
pubmed: 30407501
J Infect Dev Ctries. 2015 May 18;9(5):505-11
pubmed: 25989170
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Health Policy Plan. 2016 Mar 8;31(7):940-953
pubmed: 26962123
BMJ Glob Health. 2017 Sep 22;2(3):e000457
pubmed: 29018588
Lancet Infect Dis. 2016 Nov;16(11):1261-1268
pubmed: 27568359
Int J Pharm Pract. 2020 Feb;28(1):13-25
pubmed: 31397533
J Clin Pharm Ther. 2012 Jun;37(3):308-12
pubmed: 21883328
S Afr Med J. 2015 Apr 06;105(5):325
pubmed: 26242647
Pharm World Sci. 2009 Dec;31(6):612-8
pubmed: 19554470
Med Educ. 2007 Jun;41(6):537-49
pubmed: 17518833
Soc Sci Med. 2003 Aug;57(4):733-44
pubmed: 12821020
BMC Public Health. 2017 Apr 19;17(1):333
pubmed: 28420365
Antimicrob Resist Infect Control. 2015 Dec 11;4:55
pubmed: 26693005
Lancet. 2017 Dec 2;390(10111):2437-2460
pubmed: 29150201
Lancet Infect Dis. 2015 Nov;15(11):1305-13
pubmed: 26268690
BMC Infect Dis. 2014 Jan 09;14:13
pubmed: 24405683
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
Malar J. 2017 Dec 19;16(1):492
pubmed: 29258505